About Aeglea Biotherapeutics

Dedicated to developing novel treatments of inborn errors of metabolism and cancer

Aeglea BioTherapeutics was founded in December 2013 to develop engineered human enzymes invented in the laboratory of George Georgiou, Ph.D. of The University of Texas at Austin. The convergence of discovery and technology has created a significant opportunity for Aeglea to potentially impact both the treatment of inborn errors of metabolism and cancer.

Contact Aeglea Biotherapeutics

Phone Number
+1 512 942 2935

More About Aeglea Biotherapeutics

Therapeutic Areas
  • Metabolic
  • Oncology
  • Diagnostics
Company Type
  • Biotechnology – Therapeutics
State of Ownership
  • Private